Andrew Callos, EVP, Chief Commercial Officer: Cytokinetics CYTK Sell · Filed 25/12/30

Trade details

Type: Insider sale
Amount: $112,953.96
Shares · price: 1,809 sh · $62.44 a share
Held after: 51,353 sh
Stock: Cytokinetics CYTK
Person: Andrew CallosEVP, Chief Commercial Officer
Trade date: 25/12/29
Filed: 25/12/30
Days to filing: 1 days

Sold 3.4% of holdings

Share of holding sold: 3.4%

Cytokinetics trades, last 26 weeks

What else happened in Cytokinetics around then

Filed or reported within 30 days of the trade day · 25/11/29~01/28

Andrew Callos's recent trades

Andrew CallosEVP, Chief Commercial Officer
Planned sale10b5-1 planCytokinetics
Planned sale10b5-1 plan
Cytokinetics
CYTK
$1.9M
24,000 sh
$1.9M
Filed 07/30
Traded 07/30
Andrew CallosEVP, Chief Commercial Officer
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$1.1M
15,000 sh
$1.1M
Filed 06/01
Traded 06/01
Andrew CallosEVP, Chief Commercial Officer
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$875.5K
11,333 sh
$875.5K
Filed 05/05
Traded 05/05
Andrew CallosEVP, Chief Commercial Officer
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$1M
15,857 sh
$1M
Filed 05/04
Traded 05/01
Andrew CallosEVP, Chief Commercial Officer
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$948.9K
15,000 sh
$948.9K
Filed 04/30
Traded 04/30